Top brand choice
Strength | Pack Size | Qty | |
---|---|---|---|
Strength
1mg
|
|||
Strength
3.5mg
|
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Velcade is a prescribed medication primarily used to address multiple myeloma, a form of cancer impacting plasma cells in the bone marrow. Additionally, it serves as a treatment for mantle cell lymphoma, an uncommon type of non-Hodgkin's lymphoma.
Bortezomib, the active component in Velcade, belongs to the proteasome inhibitor class of drugs. It hinders the function of proteasomes, which are cellular structures responsible for protein breakdown. By blocking proteasomes, it disrupts cancer cell growth and survival.
Fact Table | |
---|---|
Formula | C19H25BN4O4 |
License | FDA approved |
Bioavailability | Approximately 64% (subcutaneous), 100% (intravenous) |
Legal status | Prescription only |
Chemical Name | (1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butylboronic acid |
Elimination half-life | Approximately 9 to 15 hours |
Dosage (Strength) | 3.5 mg/vial for injection |
Pregnancy | Not recommended; consult a healthcare provider |
Brands | Velcade |
Protein binding | Approximately 83% |
PubChem CID | 387447 |
MedlinePlus | a605007 |
ChEBI | 49575 |
ATC code | L01XX32 |
DrugBank | DB00188 |
KEGG | D03497 |
Routes of administration | Intravenous, Subcutaneous |
Take Velcade exactly as prescribed by your healthcare provider. It is administered only by trained healthcare professionals.
The active ingredient in Velcade is bortezomib.
Tell your doctor and pharmacist if you are taking any of the following:
Before starting Velcade, review your medical conditions or concerns with your healthcare provider. Inform your doctor of any history of peripheral neuropathy, heart disease, liver disease, kidney disease, lung disease, or herpes zoster.
Avoid using Velcade if you are pregnant or planning to become pregnant.
Common adverse reactions to be aware of include:
Velcade [package insert]. Cambridge, MA: Millennium Pharmaceuticals; June 2008.